| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |